Jing Jia

Jing Jia


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in ASN Neuro
Verified
Journal Article
Open access
XZXian-Si Zeng
Xian-Si Zeng
WGWen-Shuo Geng
Wen-Shuo Geng
JJJing Jia
Jing Jia
Parkinson disease (PD) is the second most common neurodegenerative movement disorder. Pharmacological animal models are invaluable tools to study the pathological mechanisms of PD. Currently, invertebrate and vertebrate animal models have been developed by using several main neurotoxins, such as 6-hydroxydopamine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, paraquat, and rotenone. These models achieve to some extent to reproduce the key features of PD, including motor defects, progressive loss of dopaminergic neurons in substantia nigra pars compacta, and the formation of Lewy bodies. In this review, we will highlight the pathogenic mechanisms of those neurotoxins and summarize different neurotoxic animal models with the hope to help researchers choose among them accurately and to promote the development of modeling PD.

17 April 2018 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
XZXian-Si Zeng
Xian-Si Zeng
WGWen-Shuo Geng
Wen-Shuo Geng
JJJing Jia
Jing Jia
LCLei Chen
Lei Chen
PZPeng-Peng Zhang
Peng-Peng Zhang
It has been 200 years since Parkinson disease (PD) was described by Dr. Parkinson in 1817. The disease is the second most common neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Although the pathogenesis of PD is still unknown, the research findings from scientists are conducive to understand the pathological mechanisms. It is well accepted that both genetic and environmental factors contribute to the onset of PD. In this review, we summarize the mutations of main seven genes (α-synuclein, LRRK2, PINK1, Parkin, DJ-1, VPS35 and GBA1) linked to PD, discuss the potential mechanisms for the loss of dopaminergic neurons (dopamine metabolism, mitochondrial dysfunction, endoplasmic reticulum stress, impaired autophagy, and deregulation of immunity) in PD, and expect the development direction for treatment of PD.

2 June 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
LGLiang Gong
Liang Gong
JYJiayi Yin
Jiayi Yin
YZYu Zhang
Yu Zhang
RHRen Huang
Ren Huang
YLYuxuan Lou
Yuxuan Lou
XZXian-Si Zeng
Xian-Si Zeng
Panax ginseng and Panax notoginseng, two well-known herbs with enormous medical value in Asian countries, have a long usage history in China for the therapy of some diseases, such as stroke. Ginsenoside Rb1 is one of most important active ingredients in Panax ginseng and Panax notoginseng. In the last two decades, more attention has focused on ginsenoside Rb1 as an antioxidative, anti-apoptotic and anti-inflammatory agent that can protect the nervous system. In the review, we summarize the neuroprotective roles of ginsenoside Rb1 and its potential mechanisms in central nervous system diseases (CNSDs), including neurodegenerative diseases, cerebral ischemia injury, depression and spinal cord injury. In conclusion, ginsenoside Rb1 has a potential neuroprotection due to its inhibition of oxidative stress, apoptosis, neuroinflammation and autophagy in CNSDs and may be a promising candidate agent for clinical therapy of CNSDs in the future.

21 February 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
XZXian-Si Zeng
Xian-Si Zeng
WGWen-Shuo Geng
Wen-Shuo Geng
ZWZhan-Qi Wang
Zhan-Qi Wang
JJJing Jia
Jing Jia
Long-term administration of morphine for the management of chronic pain will result in tolerance to its analgesic effect and could even cause drug dependence. Numerous studies have demonstrated significant redox alteration in morphine dependence and addiction. Thioredoxin-1 (Trx-1) play important roles in controlling the cellular redox balance. In recent years, several recent studies have demonstrated that Trx-1 may be a promising novel therapeutic target for morphine addiction. In this article, we firstly review the redox alteration in morphine addiction. We also summarize the expression and the protective roles of Trx-1 in morphine dependence. We further highlight the protection of geranylgeranylacetone (GGA), a noncytotoxic pharmacological inducer of Trx-1, in morphine-induced conditioned place preference. In conclusion, Trx-1 may be very promising for clinical therapy of morphine addiction in the future.

7 September 2015 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
XZXian-Si Zeng
Xian-Si Zeng
JJJing Jia
Jing Jia
LMLi-Fang Ma
Li-Fang Ma

21 December 2023 in Neural Regeneration Research
Verified
Journal Article
Open access
BHBo Hu
Bo Hu
JZJiaping Zhang
Jiaping Zhang
JHJie Huang
Jie Huang
BLBairu Luo
Bairu Luo
XZXiansi Zeng
Xiansi Zeng
JJJing Jia
Jing Jia
The inflammasome is a multiprotein complex involved in innate immunity that mediates the inflammatory response leading to pyroptosis, which is a lytic, inflammatory form of cell death. There is accumulating evidence that nucleotide-binding domain and leucine-rich repeat pyrin domain containing 3 (NLRP3) inflammasome-mediated microglial pyroptosis and NLRP1 inflammasome-mediated neuronal pyroptosis in the brain are closely associated with the pathogenesis of Alzheimer’s disease. In this review, we summarize the possible pathogenic mechanisms of Alzheimer’s disease, focusing on neuroinflammation. We also describe the structures of NLRP3 and NLRP1 and the role their activation plays in Alzheimer’s disease. Finally, we examine the neuroprotective activity of small-molecule inhibitors, endogenous inhibitor proteins, microRNAs, and natural bioactive molecules that target NLRP3 and NLRP1, based on the rationale that inhibiting NLRP3 and NLRP1 inflammasome-mediated pyroptosis can be an effective therapeutic strategy for Alzheimer’s disease.